References
- MatucciACammelliDCantiniFInfluence of anti-TNF immunogenicity on safety in rheumatic disease: a narrative reviewExpert Opin Drug Saf201615Suppl 131027924646
- SchneiderMKrügerKRheumatoid arthritis-early diagnosis and disease managementDtsch Arztebl Int201311027–2847748423964304
- SinghJASaagKGBridgesSLJr2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritisArthritis Rheumatol2016681126
- HoCHChauhanKLupus Erythematosus, Drug-InducedTreasure Island (FL)StatPearls Publishing2017
- ArnettFCEdworthySMBlochDAThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum19883133153243358796
- van RielPLThe development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28)Clin Exp Rheumatol2014325 Suppl 85S65S74
- PetriMOrbaiAMAlarconGSDerivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis Rheum20126482677268622553077
- HahnBHMcMahonMAWilkinsonAAmerican College of RheumatologyAmerican College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisArthritis Care Res (Hoboken)201264679780822556106
- GinzlerEConnective tissue diseases: management of lupus nephritis-new guidelines revealedNat Rev Rheumatol201281056556622847470
- AndersHJAppelGBLupus nephritis: implications of the new ACR lupus nephritis guidelinesNat Rev Nephrol20128950050122825673
- PapoTPolyvalent intravenous immunoglobulins in systemic lupusRev Med Interne199920Suppl 4S414S418 French
- LespritPMouloudFBierlingPProlonged remission of SLE-associated polyradiculoneuropathy after a single course of intravenous immunoglobulinScand J Rheumatol19962531771798668963
- WeeningJJD’AgatiVDSchwartzMMRenal Pathology Society Working Group on the Classification of Lupus NephritisThe classification of glomerulonephritis in systemic lupus erythematosus revisitedKidney Int200465252153014717922
- Pérez-De-LisMRetamozoSFlores-ChávezAAutoimmune diseases induced by biological agents. A review of 12,731 cases (BIO-GEAS registry)Expert Opin Drug Saf201716111255127128854831
- VannucchiVGrazziniMPieralliFGiannottaMBiagioniCNozzoliCAdalimumab-induced lupus erythematosus with central nervous system involvement in a patient with Crohn’s diseaseJ Gastrointestin Liver Dis201120220120321725519
- PortuesiMGPerosaPNephrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case reportReumatismo20086016163 Italian18432327
- MartínJMRicartJMAlcácerJRausellNAranaGAdalimumab-induced lupus erythematosusLupus200817767667818625641
- Ramos-CasalsMBrito-ZeronPMunozSAutoimmune diseases induced by TNF-targeted therapies analysis of 233 casesMedicine (Baltimore)200786424225117632266